We are live on ! Find out more
Cantor Fitzgerald

Cantor Fitzgerald Portfolio holdings

AUM $10.4B Turnover 72.96%
1-Year Est. Return 69.81%
 

Cantor Fitzgerald is an investment bank and brokerage that Bernard Gerald Cantor and John Fitzgerald formed in 1945. In 1965 it began selling and trading large blocks of stock for institutional customers. Bernie Cantor led the firm until his death in 1996, and Howard Lutnick then headed it until 2025. Its headquarters in the World Trade Center's North Tower, used until 2001, were destroyed in the September 11 attacks, and the firm later rebuilt its infrastructure and moved to Midtown Manhattan. Its affiliate BGC Partners, a global brokerage company, is named after founder B. Gerald Cantor.

This Fund
S&P 500
This Quarter Est. Return
+11.2%
1 Year Est. Return
+69.81%
3 Year Est. Return
+438.92%
5 Year Est. Return
+462.9%
10 Year Est. Return
–
AUM
$10.4B
AUM Growth
+$1.1B
Cap. Flow
+$40M
Cap. Flow %
0.38%
Top 10 Hldgs %
43.08%
Holding
884
New
564
Increased
97
Reduced
110
Closed
81
Avg Time Held Equity + Options
0.3 years
Top 10 Avg Time Held Equity + Options
0.6 years
Top 20 Avg Time Held Equity + Options
0.5 years
Avg Time Held Equity only
0.2 years
Top 10 Avg Time Held Equity only
0.5 years
Top 20 Avg Time Held Equity only
0.7 years

Top Sells

Rank Stock Value
1
MRVL icon
Marvell Technology
MRVL
+$476M
2
AMD icon
Advanced Micro Devices
AMD
+$300M
3
NVDA icon
NVIDIA
NVDA
+$174M
4
NOW icon
ServiceNow
NOW
+$145M
5
AVGO icon
Broadcom
AVGO
+$123M

Sector Composition

Rank Sector Weight
1 Miscellaneous 54.68%
2 Technology 24.05%
3 Financials 6.98%
4 Industrials 4.77%
5 Communication Services 2.97%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow Held Since
ITRG icon
476
Integra Resources
ITRG
$290M
$456K ﹤0.01%
+177,556
New +$449K
2026 Q3
0 quarters
RARE icon
477
PUT
Ultragenyx Pharmaceutical
RARE
$1.68B
$451K ﹤0.01%
+30,000
New +$720K
2026 Q3
0 quarters
HCAC icon
478
Hall Chadwick Acquisition Corp
HCAC
$299M
$451K ﹤0.01%
44,500
– –
2026 Q1
2 quarters
BLSH icon
479
Bullish
BLSH
$2.89B
$450K ﹤0.01%
12,910
-2,340
-15% -$68.1K
2026 Q2
1 quarter
WATR icon
480
Air Water Ventures
WATR
$45M
$449K ﹤0.01%
+264,000
New +$551K
2026 Q3
0 quarters
QURE icon
481
CALL
uniQure
QURE
$1.36B
$447K ﹤0.01%
+18,500
New +$802K
2026 Q3
0 quarters
IAUX icon
482
i-80 Gold
IAUX
$912M
$441K ﹤0.01%
+265,801
New +$424K
2026 Q3
0 quarters
CELH icon
483
Celsius Holdings
CELH
$7.13B
$440K ﹤0.01%
+16,104
New +$478K
2026 Q3
0 quarters
BP icon
484
BP
BP
$110B
$433K ﹤0.01%
+9,835
New +$422K
2026 Q3
0 quarters
PLUG icon
485
Plug Power
PLUG
$1.34B
$432K ﹤0.01%
222,443
+74,743
+51% +$162K
2026 Q2
1 quarter
UPST icon
486
Upstart Holdings
UPST
$1.55B
$426K ﹤0.01%
+18,539
New +$531K
2026 Q3
0 quarters
GFS icon
487
GlobalFoundries
GFS
$19.8B
$423K ﹤0.01%
+8,819
New +$459K
2026 Q3
0 quarters
ROKU icon
488
DELISTED
Roku
ROKU
$419K ﹤0.01%
+2,754
New +$414K
2026 Q3
0 quarters
VMC icon
489
Vulcan Materials
VMC
$34.8B
$415K ﹤0.01%
+1,695
New +$461K
2026 Q3
0 quarters
LRCX icon
490
Lam Research
LRCX
$229B
$414K ﹤0.01%
+1,260
New +$393K
2026 Q3
0 quarters
CNH icon
491
CNH Industrial
CNH
$17.2B
$413K ﹤0.01%
+32,177
New +$376K
2026 Q3
0 quarters
MLTX icon
492
MoonLake Immunotherapeutics
MLTX
$942M
$410K ﹤0.01%
+35,000
New +$572K
2026 Q3
0 quarters
ORIC icon
493
CALL
Oric Pharmaceuticals
ORIC
$765M
$404K ﹤0.01%
+30,000
New +$374K
2026 Q3
0 quarters
CTNM icon
494
CALL
Contineum Therapeutics
CTNM
$341M
$403K ﹤0.01%
+30,000
New +$447K
2026 Q3
0 quarters
KORU icon
495
Direxion Daily MSCI South Korea Bull 3X ETF
KORU
$577M
$400K ﹤0.01%
+20,001
New +$416K
2026 Q3
0 quarters
EQX icon
496
Equinox Gold
EQX
$10B
$398K ﹤0.01%
+35,851
New +$400K
2026 Q3
0 quarters
SPY icon
497
State Street SPDR S&P 500 ETF Trust
SPY
$732B
$397K ﹤0.01%
+520
New +$395K
2026 Q3
0 quarters
LIN icon
498
Linde
LIN
$231B
$395K ﹤0.01%
+832
New +$409K
2026 Q3
0 quarters
FAC icon
499
Factorial Energy
FAC
$369M
$394K ﹤0.01%
+62,118
New +$370K
2026 Q3
0 quarters
QCOM icon
500
Qualcomm
QCOM
$160B
$393K ﹤0.01%
+2,134
New +$369K
2026 Q3
0 quarters

Similar funds

Cantor Fitzgerald's Q3 2026 Portfolio in Review

As of Q3 2026, Cantor Fitzgerald held 884 positions worth $10.4B, up 12% from $9.31B the previous quarter. Its ten largest holdings account for 43% of the portfolio.

Cantor Fitzgerald's Q3 2026 filing shows 564 new, 97 increased, 110 reduced and 81 closed positions. Its largest new stake was Equifax: 778,818 shares worth $107M. The largest sale was Marvell Technology, an estimated $476M.

By sector, the portfolio is most concentrated in Miscellaneous at 55% of assets, up from 47% a quarter earlier, followed by Technology and Financials.

  • Cantor Fitzgerald's largest Q3 2026 buy was Equifax: 778,818 shares worth $107M.
  • Cantor Fitzgerald added most to Strategy Inc in Q3 2026, an estimated $200M increase.
  • Cantor Fitzgerald's biggest Q3 2026 reduction was Marvell Technology, cutting an estimated $476M.
  • Cantor Fitzgerald fully exited Walmart in Q3 2026, selling an estimated $13.6M.
  • Cantor Fitzgerald's ten largest holdings make up 43% of its $10.4B portfolio in Q3 2026.
  • Cantor Fitzgerald opened 564 new positions and closed 81 in Q3 2026.
  • Cantor Fitzgerald's portfolio value rose 12% quarter-over-quarter to $10.4B.

Based on Cantor Fitzgerald's 13F filing for Q3 2026, filed 16 Nov 2026.